Ratings by William Blair (Tim Lugo)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/15/2021 Sage Therapeutics SAGE Downgrade Market Perform
(Outperform)
72.86
(55.69)
-23.57% Details
1/4/2021 VistaGen Therapeutics VTGN Upgrade Outperform
(Market Perform)
1.94
(2.62)
35.05% Details
11/24/2020 Atea Pharmaceuticals AVIR New Coverage Outperform
(N/A)
33.54
(23.45)
-30.08% Details
9/23/2020 9 Meter Biopharma NMTR New Coverage Outperform
(N/A)
0.69
(1.38)
100% Details
6/26/2020 Zogenix, Inc. ZGNX Maintain Outperform
(N/A)
 
 
  Details
6/5/2020 Adamas Pharmaceuticals ADMS Maintain Outperform
(N/A)
 
 
  Details
6/3/2020 BVHN Maintain Outperform
(N/A)
 
 
  Details
5/26/2020 Lyra Therapeutics LYRA New Coverage Outperform
(N/A)
14.43
(8.08)
-44.01% Details
2/3/2020 Agile Therapeutics AGRX Maintain Outperform
(N/A)
 
 
  Details
1/8/2020 Xenon Pharmaceuticals XENE New Coverage Outperform
(N/A)
14.73
(18.27)
24.03% Details
12/10/2019 Biohaven Pharmaceutical Holding BHVN Maintain Outperform
(N/A)
 
 
  Details
11/14/2019 VistaGen Therapeutics VTGN Downgrade Market Perform
(Outperform)
1.08
(2.62)
142.59% Details
10/31/2019 argenx SE ARGX Upgrade Outperform
(Market Perform)
119.14
(315.81)
165.07% Details
9/17/2019 Collegium Pharmaceutical COLL Maintain Outperform
(N/A)
 
 
  Details
8/28/2019 VistaGen Therapeutics VTGN New Coverage Outperform
(N/A)
0.64
(1.08)
68.75% Details
6/25/2019 Acer Therapeutics ACER Downgrade Market Perform
(Outperform)
19.28
(2.81)
-85.43% Details
12/20/2018 Shire SHPG Downgrade Market Perform
(Outperform)
168.73
(179.20)
6.21% Details
8/13/2018 Allakos Inc. ALLK New Coverage Outperform
(N/A)
37.27
(90.74)
143.47% Details